CYP11B2 and Primary hyperaldosteronism: CYP11B2 expression was reported to be upregulated in PBMCs of primary hyperaldosteronism (PA) patients as compared to healthy subjects and patients with Aldo-producing adenoma (Miyamori et al. 2000).